Clinical Trial Update: Efficacy and Safety Study Comparing CD07805/47 Gel 0.5% to Azelaic Acid Gel 15% in Subjects With Erythema of Rosacea [Phase 3]

View source ↗

Summary

Phase 3 trial comparing CD07805/47 Gel 0.5% to azelaic acid gel 15% for erythema of rosacea completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erythema
• Rosacea

Drugs mentioned

• Azelaic acid gel 15% (azelaic acid)
• CD07805/47 Gel 0.5% (CD07805/47 Gel 0.5%)

Snippet

Sponsor: Galderma R&D | Conditions: Erythema, Rosacea | Phase 3 | Status: COMPLETED | Results posted: 2014-07-10